Venture
Neurona Therapeutics, Inc
Latest Form D 2025-04-04- CIK 1443321
- State CA
- Biotechnology
- 6 Form D offerings since 2014-12-23
- Total sold
- $347M
- across 6 offerings
- Rounds
- 6
- Form D offerings since 2014-12-23
- Latest round
- $102M
- 2025-04-04 · 021-543006
- Investors
- 46
- on the latest round
Connected
named in its Form D filingsOfferings · since 2014-12-236 Form D offeringsExemptions506(b)People · Item 3Cory Nicholas + 7 moreInvestors · dashboard2 inferred investors
Neurona Therapeutics, IncCIK 1443321
Round timeline
amount sold · by first filed2025-04-04 · $102M
- 2014-12-23$28.7M021-230717
- 2018-02-27$10M021-306460
- 2019-11-25$15M021-354176
- 2021-03-29$72M021-393804
- 2024-02-13$120M021-505128
- 2025-04-04$102M021-543006
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($120M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-543006 | First filed2025-04-04 | Latest2025-04-04 | Sought$102M | Sold$102M | Investors46 | Exemptions506(b) |
| 021-505128 | First filed2024-02-13 | Latest2024-02-13 | Sought$120M | Sold$120M | Investors35 | Exemptions506(b) |
| 021-393804 | First filed2021-03-29 | Latest2022-12-23 | Sought$91.6M | Sold$72M | Investors21 | Exemptions506(b) |
| 021-354176 | First filed2019-11-25 | Latest2019-11-25 | Sought$50M | Sold$15M | Investors9 | Exemptions506(b) |
| 021-306460 | First filed2018-02-27 | Latest2018-02-27 | Sought$20M | Sold$10M | Investors6 | Exemptions506(b) |
| 021-230717 | First filed2014-12-23 | Latest2016-12-28 | Sought$30.3M | Sold$28.7M | Investors13 | Exemptions506(b) |
Who backs Neurona Therapeutics, Inc — 2 inferred investors — and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2025-04-04
| Name | Relationship |
|---|---|
| Cory Nicholas | RelationshipExecutive Officer, Director, Promoter |
| James Stutz | RelationshipExecutive Officer |
| Tim Kutzkey | RelationshipDirector |
| Leo Guthart | RelationshipDirector |
| Ray Kelleher | RelationshipDirector |
| Brad Margus | RelationshipDirector |
| Erica Whittaker | RelationshipDirector |
| Peter Svennilson | RelationshipDirector |
Facts
As its latest Form D states them
- Industry
- Biotechnology
- State
- California (CA)
- Exemptions
- Rule 506(b)
- First filed
- 2014-12-23
- Latest filing
- 2025-04-04
Who backs Neurona Therapeutics, Inc
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗